NorthWest Biotherapeutics Inc (NWBO)

[Goodtime13]

This would be the Smith on Stocks point of view. That regulators are allowing the trial to continue - even though it will most likely fail or has failed (via an Interim analysis) to gather valuable data.

Not sure I agree with this.

a. If it had failed why would NWBO continue to pay for the trial for over a year....

b. Not sure the FDA would allow this...

c. I can plausibly see there not being enough events yet....

d. 13 months after a screening hold is a long time....

What may be plausible is that an interim analysis showed a failure in PFS but NWBO is arguing that if the trial continues overall survival will prove significant and that in itself should make L approvable.

Who knows.....I am in the same situation as you PharmD